Philips Outperforms Peers as Q3 Print Looms

Koninklijke Philips N.V. rose 0.7% over the past week, a quiet but meaningful contrast with its closest correlated peers, most of which fell. ISRG dropped 4.5% on the week and IDXX fell 1.6%, while GEHC was the outlier on the other side, up 7.2%. Against a peer median of roughly minus 0.8%, Philips' flat-to-positive week stands out, even if the margin is modest.

The borrow market for Philips is genuinely uncrowded. Availability sits at roughly 2,661%, meaning there are more than 26 shares available to lend for every one currently borrowed. That is well above the 52-week floor of 179%, and the cost to borrow has fallen sharply: down 26% on the week and 50% over the past month to 0.58%. Short sellers are not pressing a case here. The stock's short score of 37.7 ranks in the 44th percentile, a middling reading that has drifted only slightly over the past two weeks, and nothing in the lending market suggests any squeeze risk or building conviction on the short side.

Ownership is the more interesting structural story. Lingotto Investment Management, the vehicle connected to the Agnelli family, holds 19% of shares outstanding and reported no change at the September quarter-end. Artisan Partners added 3.3 million shares to bring its position to 7.2% of the company. T. Rowe Price and Causeway Capital also added meaningfully in recent periods. The list of buyers is long relative to sellers, and the register skews toward active value-oriented managers rather than passive flows.

Valuation multiples have moved in one direction over the past month. The price-to-book ratio has expanded by roughly 0.2 turns over 30 days to 1.93. The PE has risen by about 1.5 points to 14.5. Neither is stretched by medtech standards, and the EV/EBITDA of 8.7 has been broadly flat. The factor scores add nuance: the company ranks in the 74th percentile on EPS surprise and earnings yield, a signal that the stock has been consistently cheap relative to its own history of beating estimates. The dividend score of 80 is a standout, though the dividend history in the data is stale and should not be read as a current yield commitment.

The one piece of data worth watching into Monday's Q3 release on 3 November is how recent earnings prints have landed. The two most recent results both produced negative one-day reactions of around 2.4% to 3.2%, with modest further weakness over the following five days. A pattern of modest post-results dips has not stopped the stock from gaining 11.5% over the past month, suggesting the market has already priced in some caution. The price-to-book expansion and the institutional buying trend are the measures to reassess once the print is out.